- Home
- REPL vs ASIX Comparison
REPL vs ASIX Comparison
Compare REPL & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- ASIX
- Stock Information
- Founded
- REPL 2015
- ASIX 2016
- Country
- REPL United States
- ASIX United States
- Employees
- REPL N/A
- ASIX N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- ASIX Major Chemicals
- Sector
- REPL Health Care
- ASIX Industrials
- Exchange
- REPL Nasdaq
- ASIX Nasdaq
- Market Cap
- REPL 780.3M
- ASIX 727.4M
- IPO Year
- REPL 2018
- ASIX N/A
- Fundamental
- Price
- REPL $11.85
- ASIX $31.87
- Analyst Decision
- REPL Strong Buy
- ASIX Strong Buy
- Analyst Count
- REPL 6
- ASIX 2
- Target Price
- REPL $17.50
- ASIX $39.50
- AVG Volume (30 Days)
- REPL 818.5K
- ASIX 142.1K
- Earning Date
- REPL 02-06-2025
- ASIX 02-21-2025
- Dividend Yield
- REPL N/A
- ASIX 2.02%
- EPS Growth
- REPL N/A
- ASIX N/A
- EPS
- REPL N/A
- ASIX 1.42
- Revenue
- REPL N/A
- ASIX $1,570,703,000.00
- Revenue This Year
- REPL N/A
- ASIX $3.94
- Revenue Next Year
- REPL $300.41
- ASIX $7.65
- P/E Ratio
- REPL N/A
- ASIX $22.28
- Revenue Growth
- REPL N/A
- ASIX 0.98
- 52 Week Low
- REPL $4.92
- ASIX $20.86
- 52 Week High
- REPL $17.00
- ASIX $33.00
- Technical
- Relative Strength Index (RSI)
- REPL 51.79
- ASIX 65.95
- Support Level
- REPL $10.05
- ASIX $26.16
- Resistance Level
- REPL $11.20
- ASIX $28.46
- Average True Range (ATR)
- REPL 0.92
- ASIX 0.94
- MACD
- REPL -0.08
- ASIX 0.55
- Stochastic Oscillator
- REPL 51.97
- ASIX 92.39
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About ASIX AdvanSix Inc.
AdvanSix Inc. is an integrated manufacturer of Nylon 6, a polymer resin and fertilizers. Nylon 6 is a synthetic material used by customers to produce engineered plastics, fibers, filaments, and films, which in turn are used in such end-products as automotive and electronic components, carpets, sports apparel, fishing nets, and food and industrial packaging. In addition, it also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process including caprolactam, ammonium sulfate fertilizers, and other chemical intermediates. Geographically, the group operates through the United States and its business is also expanding internationally but it derives the majority of its revenue from the United States region.